Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Elranatamab for Multiple Myeloma
Recruiting2 awardsPhase 3
Longmont, Colorado
"This trial is testing a new medication called elranatamab for the treatment of a type of cancer called MM. Participants in the trial must be 18 years or older with MM that has returned
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service